igf-1 lr3 cycle results Recombinant Human IGF-I/IGF-1 GMP Protein, CF 8335D-GMP: R&D Systems Igf 1 Growth Results 3

Morel GR, Leon ML, Uriarte M, Reggiani PC, Goya RG

KimuraSTagamiSManoHKittakaAIdaYTakagiYet al

Daily dose: 2,330mcg (2.33mg) total blend This breaks down to approximately: 1,700mcg (1.7mg) GHK-Cu 330mcg TB-500 330mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks, followed by 2-4 week rest period Schedule: Daily injection at consistent time For a standard 70mg glow peptide vial reconstituted with 3mL bacteriostatic water, this protocol requires 0.10mL (10 units on an insulin syringe) per daily injection

A number of publications have investigated depression based on epigenetics [86, 87]